Hinge Health Q4 2025 Earnings Call Summary

1Key Financial Results and Metrics

Q4 Revenue: $171 million, up 46% year-over-year.

Full Year 2025 Revenue: $588 million, a 51% increase from 2024.

Calculated Billings: $671 million for the last 12 months, a 44% year-over-year growth.

Gross Margin: 85% in Q4 and 83% for the full year, reflecting operational efficiency.

Operating Margin: 28% in Q4 and 20% for the full year, showing significant improvement from previous years.

Free Cash Flow: $62 million in Q4 (36% margin) and $180 million for the full year (31% margin).

Rule of 40 Metric: 81% for the full year, indicating strong growth and profitability.

2Strategic Updates and Business Highlights

Market Reach: Expanded to nearly 25 million contracted lives across over 2,800 clients, a 25% increase year-over-year.

AI Initiatives: Significant advancements in AI tools improved care delivery efficiency; member satisfaction scores reached an all-time high.

HingeSelect Launch: A high-performance provider network now available to several hundred thousand eligible lives, with promising early data showing cost savings and improved member outcomes.

Sales Success: Exceptional sales season with 4.8 million net new contracted lives added, including significant wins from competitors.

3Forward Guidance and Outlook

Q1 2026 Revenue Guidance: Expected to be between $171 million and $173 million, representing 39% year-over-year growth.

Full Year 2026 Revenue Guidance: Projected between $732 million and $742 million, indicating 25% growth at the midpoint.

Operating Profit Guidance: Anticipated non-GAAP income from operations of $151 million to $156 million for 2026, with a 21% margin.

4Challenges and Points of Concern

Yield Expectations: Yield is expected to remain flat in 2026, which may limit revenue growth potential despite strong member engagement.

Competitive Pressures: The market is seeing consolidation among competitors, though Hinge Health has maintained a strong competitive win rate.

HingeSelect Revenue Impact: No significant revenue contribution from HingeSelect expected until 2027, indicating a longer timeline for realizing its potential.

5Notable Q&A Insights

Competitive Moats: CEO Daniel Perez emphasized Hinge's competitive advantages beyond software, including proprietary data and established distribution channels.

Member Engagement: First-year cohorts showed improved engagement metrics, suggesting potential for continued growth in yield.

TAM Expansion: Discussions on expanding beyond physical therapy into preventive care were noted, but the focus remains on capturing existing market opportunities.

M&A Strategy: Hinge Health is open to tuck-in acquisitions but is primarily focused on organic growth and enhancing its existing offerings. Overall, Hinge Health reported a strong performance in 2025, with significant growth in revenue and member engagement, while also outlining a cautious but optimistic outlook for 2026 amidst competitive pressures and strategic investments in new initiatives.